CEL-SCI CORPORATION Inventory
CEL-SCI CORPORATION (CVM) had Inventory of $1.02 million as of 2024-09-30, per its 10-K filed 2025-01-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2025-01-13
- 2024-09-30: Inventory, Net $1.02M.
- 2023-12-31: Inventory, Net $2.35M.
- 2023-09-30: Inventory, Net $2.25M.
- 2022-09-30: Inventory, Net $2.00M.
| Period end | Inventory, Net |
|---|---|
| 2024-09-30 | $1.02M 10-K · filed 2025-01-13 |
| 2023-12-31 | $2.35M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $2.25M 10-K · filed 2025-01-13 |
| 2022-09-30 | $2.00M 10-K · filed 2023-12-21 |
| 2021-09-30 | $2.01M 10-K · filed 2022-12-27 |
| 2021-06-30 | $1.58M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.46M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.15M 10-Q · filed 2021-02-12 |
| 2020-09-30 | $820.05K 10-K · filed 2021-12-21 |
| 2020-06-30 | $787.01K 10-Q/A · filed 2020-12-31 |
| 2020-03-31 | $849.55K 10-Q/A · filed 2020-12-30 |
| 2019-12-31 | $905.88K 10-Q/A · filed 2020-12-30 |
| 2019-09-30 | $782.36K 10-Q/A · filed 2020-12-31 |
| 2019-06-30 | $754.83K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $761.01K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $682.52K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $645.24K 10-K/A · filed 2019-12-23 |
| 2018-06-30 | $628.16K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $630.31K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $644.75K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $672.52K 10-K · filed 2018-12-19 |
| 2017-06-30 | $657.74K 10-Q/A · filed 2017-12-11 |
| 2017-03-31 | $678.66K 10-Q/A · filed 2017-12-11 |
| 2016-12-31 | $694.50K 10-Q/A · filed 2017-12-11 |
| 2016-09-30 | $1.01M 10-K · filed 2017-12-29 |
| 2016-06-30 | $1.26M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.34M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $1.40M 10-K/A · filed 2017-12-11 |
| 2015-06-30 | $1.42M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $1.57M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.24M 10-Q · filed 2015-02-06 |
| 2014-09-30 | $1.45M 10-K · filed 2015-12-11 |
| 2014-06-30 | $1.41M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $1.42M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.35M 10-Q · filed 2014-02-10 |
| 2013-09-30 | $1.02M 10-K · filed 2014-12-23 |
| 2013-06-30 | $1.14M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $1.29M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.14M 10-Q · filed 2013-02-08 |
| 2012-09-30 | $1.38M 10-K · filed 2013-12-27 |
| 2012-06-30 | $1.37M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $1.37M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $1.37M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $1.57M 10-K · filed 2012-12-14 |
| 2011-06-30 | $1.58M 10-Q · filed 2011-08-09 |
| 2010-09-30 | $1.48M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |